Evotec AG. (2/7/19). "Press Release: Evotec Mourns Loss of Company Co-founder Prof. Manfred Eigen". Hamburg.

	Organisation	Evotec AG (FSE: EVT, TecDAX)
	Today	Evotec SE (FSE: EVT, MDA X/TecDAX, Nasdaq: EVO)
	Group	Evotec (Group)
	Organisation 2	Max Planck Institute for Biophysical Chemistry (MPI-BPC) (Goettingen)
	Group	Max Planck Society for the Advancement of Science
	Product	chemistry (science)
	Product 2	drug discovery
	Person	Eigen, Manfred
	Person 2	Lanthaler, Werner (Evotec AG 200903– CEO before Intercell AG CFO before Austrian Industrial Assoc before McKinsey)

Evotec AG mourns the loss of Nobel laureate and Company co-founder Prof. Manfred Eigen, who passed away Wednesday at the age of 91.

Prof. Eigen was born in Bochum in 1927 into a family of musicians. When the Second World War crossed his original plans to study music as well, Manfred Eigen decided to study the “harmonies” of molecules, instead. In 1967, the biophysical chemist received the Nobel Prize in Chemistry. He founded the Max Planck Institute for Biophysical Chemistry (MPI-BPC) in Goettingen, and was among the co-founders of Evotec in 1993.

Evotec’s board and the workforce will remember Prof. Eigen as a true innovator whose vision of evolutionary biotechnology laid the foundation of modern-day drug discovery. Prof. Eigen always maintained close connections with Evotec, and was a guest of honour when the Company opened its research site in Hamburg in 2012. The site, which was named “Manfred Eigen Campus” in his honour remains Evotec’s headquarters to this day.

Dr Werner Lanthaler, Chief Executive Officer of Evotec, said: “It is with great sadness, that we have received the news about the passing of our company’s co-founder Prof. Manfred Eigen, one of the great geniuses of our time. It is simply impossible to overstress the profound influence that Manfred Eigen’s work has had on modern drug discovery. Our thoughts are with his wife, Dr. Ruthild Oswatitsch-Eigen, and his family.”

Record changed: 2023-06-05